Der var mindre brug af smertestillende morfika (p < 0, 01), smertestillende ikke- morfika (p < 0, 01), anden ikke- sygdomsrelateret medicin (p = 0, 06) og strålebehandling (p < 0, 01) hos de patienter, der fik behandling med docetaxel ved doseringen 75 mg/ m2 end hos patienterne, der fik bedste palliative behandling.
There was less use of morphinic analgesic (p < 0.01), non-morphinic analgesics (p < 0.01), other disease-related medications (p = 0.06) and radiotherapy (p < 0.01) in patients treated with docetaxel at 75 mg/ m² compared to those with BSC.